Alkem Laboratories gets 3 observations from USFDA for St Louis facility

07 Feb 2020 Evaluate

Alkem Laboratories has received three observations from the American health regulator after inspection of its facility at St Louis in the US. The United States Food and Drug Administration (USFDA) had conducted an inspection of the company's manufacturing facility located at St. Louis, USA from January 27 to February 6, 2020.

At the end of the inspection, the company has received Form 483 with three observations. The company shall submit to the USFDA within the stipulated timeline a detailed response to close out all the observations associated with this inspection.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5461.00 -38.75 (-0.70%)
30-Dec-2025 11:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1266.50
Cipla 1486.45
Zydus Lifesciences 903.00
Lupin 2081.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×